### 58. notes that cancer patients are frequently affected by medicine shortages; calls on the commission to present a specific strategy for managing shortages of all medicines and medical products in europe and of cancer medicines in particular; supports the development of a common basket of the cancer drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment; ### 58. notes that cancer patients are frequently affected by medicine shortages; calls on the commission to present a specific strategy for managing shortages of all medicines and medical products in europe and of cancer medicines in particular; underlines specifically the fundamental issues posed by the shortage of paediatric medicines; underscores that articles 24 and 35 of the eu charter of fundamental rights and article 168 of teu prescribe that children have the right to a high level of human health protection and to care , as is necessary for their wellbeing , as well as to high quality and safe medicines; supports the development of a common basket of the cancer drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment;


### 58. notes that cancer patients are frequently affected by medicine shortages; calls on the commission to present a specific strategy for managing shortages of all medicines and medical products in europe and of cancer medicines in particular; supports the development of a common basket of the cancer drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment; ### 58. notes that cancer patients are frequently affected by medicine shortages; calls on the commission to present a specific strategy for managing shortages of all medicines and medical products in europe and of cancer medicines in particular; calls on the commission to start an inquiry into the effects of parallel trade on medicine shortages; supports the development of a common basket of the cancer drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment;


### 59. calls for the reinforcement and diversification of the supply chain , in particular that of cancer drugs , within the eu , close monitoring of medicine tensions and shortages , and the creation of a strategic stockpile of such medicines; ### 59. calls for the reinforcement and diversification of the supply chain , in particular that of cancer drugs , within the eu , close monitoring of medicine tensions and shortages at eu level , and the creation of a strategic stockpile of such medicines; urges the commission , in the context of the eu public procurement directive 2014/24/eu , to develop guidelines to support public procurement practices in the pharmaceutical field for cancer drugs , not relying exclusively or prominently on the criterion of price , in order to foster the sustainability of the supply chain and the resilience of the national health systems , and to avoid a delocalization aimed at reducing the costs of manufacturing;


### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed; ### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed; calls on the commission to address the misuse of the ipr (industrial property rights) system to delay market entry of generic and biosimilar medicines;


### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed; ### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition , innovation and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed;


### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments; ### 61. considers that member states should converge on evidence-based scientific evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments;


### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments; ### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised and faster access to innovative cancer diagnosis and treatments;


### 63. strongly advocates the extension of joint procurement procedures for cancer medicines to improve affordability and access to cancer treatments at eu level; ### 63. strongly advocates the extension of joint procurement procedures for cancer medicines to improve affordability and access to cancer treatments at eu level; considers , in this respect , that special attention should be given to paediatric cancers and rare cancers;


### 63. strongly advocates the extension of joint procurement procedures for cancer medicines to improve affordability and access to cancer treatments at eu level; ### 63. strongly advocates the extension of joint procurement procedures for cancer medicines and cancer preventing vaccines like hpv and hepatitis b vaccines to improve affordability and access to cancer treatments at eu level;


### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials carried out in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life; ### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials carried out in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life; urges for a fresh review of opportunities to reduce the bureaucracy associated to clinical trials , as well as long-term learning from the covid-19 pandemic on future forms of international trial cooperation and information-sharing;


### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials carried out in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life; ### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials carried out across europe in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life;


### 69. supports the development of clinical trials on the use of new cancer drugs in adults and children; ### 69. supports the development of clinical trials for the discovery of improved forms of treatment and care for patients , including children and older patients;


### 69. supports the development of clinical trials on the use of new cancer drugs in adults and children; ### 69. supports the development of clinical trials on the use of new and affordable cancer drugs in adults and children;


### 69. supports the development of clinical trials on the use of new cancer drugs in adults and children; ### 69. supports the development of clinical trials across europe on the use of new cancer drugs in adults and children;


### 70. welcomes the commission’s intention to adopt a legislative proposal to establish a health emergency preparedness and response authority (hera) in order to anticipate , incentivise , co-develop and facilitate rapid , equal and sustainable access to cancer innovations for cancer patients; calls for a large consortium of public authorities , private companies and ngos , including patient associations , to work together to guarantee the accessibility and affordability of cancer treatment options requiring complex technologies , for instance , cellular therapy (car t cells) , adoptive immunotherapy through the use of tumour genome extracts (messenger rna) and nanotechnologies; ### 70. welcomes the commission’s intention to adopt a legislative proposal to establish a health emergency preparedness and response authority (hera) in order to anticipate , incentivise , co-develop and facilitate rapid , equal and sustainable access to cancer innovations for cancer patients; calls for a large consortium of public authorities , private companies and ngos , including patient associations , to work together to guarantee the accessibility and affordability of cancer treatment options requiring complex technologies , for instance , cellular therapy (car t cells) , adoptive immunotherapy through the use of tumour genome extracts (messenger rna) and nanotechnologies; urges that health workforce planning and resilience be within the remit of the health emergency preparedness and response authority;


### iii.c . equal access to cancer care: towards a better response to the impact of health crises on cancer patients ### iii.c . equal access to integrated , multidisciplinary and quality cancer care: towards a better response to the impact of health crises on cancer patients


### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays in screening , referral and surgical procedures , treatment postponement , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and reduced communication with health professionals; ### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays in prevention activities such as hpv vaccination , screening , referral and surgical procedures , treatment postponement , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and reduced communication with health professionals; highlights evidence suggesting that clinicians across europe saw 1.5 million fewer cancer patients in the first year of the pandemic , an estimated 100 million cancer screening tests were not performed in europe as a result of the pandemic , and consequently , 1 million citizens in the eu may presently be undiagnosed with cancer as a consequence of the covid-19 pandemic;


### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays in screening , referral and surgical procedures , treatment postponement , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and reduced communication with health professionals; ### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays in screening , referral , diagnosis and surgical procedures , treatment postponement , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and reduced communication with health professionals;


### 72. considers that the covid-19 pandemic was a real stress test for the eu’s health systems; underlines that the main lesson learned should be the need to build an emergency strategy to allow member states to react accordingly in times of any future health crises; stresses that specific measures under this emergency strategy should be aimed at the protection of vulnerable groups , including cancer patients; ### 72. considers that the covid-19 pandemic was a real stress test for the eu’s health systems; underlines that the main lesson learned should be the need to build an emergency strategy to allow member states to react accordingly in times of any future health crises; stresses that vulnerable groups , including cancer patients , are particularly exposed during a health crisis; stresses that specific measures under this emergency strategy – including e.g. advance purchase agreements (apas) – should support the development , production and stockpiling of products to protect these vulnerable groups;


### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; ### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; recognises the fact that the pandemic has increased the care burden for informal carers , who provide most of the daily care required by cancer patients and who need (practical and policy) support;


### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; ### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; suggests that the cancer inequalities registry may serve a function in measuring and reporting on pre-existing workforce shortages;


### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; ### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals in both primary and specialised care;


### 74. advocates the development of a digital health system to monitor symptoms and ensure cancer treatment and care at home; calls for permanent access to medical consultations and psychosocial services to be guaranteed through the use of telemedicine or in health threat-free environments in hospitals; ### 74. advocates the development of a digital health system to monitor symptoms and ensure cancer treatment and care at home; calls for permanent access to medical consultations and psychosocial services to be guaranteed through the use and integration of telemedicine within the healthcare systems or in health threat-free environments in hospitals;


### 75. asks for enhanced communication between health professionals , patients and public authorities regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , and for increased awareness campaigns in times of crises; ### 75. asks for enhanced communication between health professionals , patients and public authorities regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , for increased awareness campaigns in times of crises , and for carrying out multidisciplinary tumour boards;


### 75. asks for enhanced communication between health professionals , patients and public authorities regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , and for increased awareness campaigns in times of crises; ### 75. asks for enhanced communication between health professionals , patients , parents , survivors and public authorities regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , and for increased awareness campaigns in times of crises;


### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination; ### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via comprehensive supportive care from a bio-psycho-social perspective (pain relief , psychological services , adapted physical activity , scientific evidence-based complementary therapies , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity) and integrated into cancer care from diagnosis and throughout the disease process; asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination; recognizes the importance of palliative care as special care for people with life threatening illness and their families , relieving pain and physical , psychosocial and spiritual suffering , while benefitting health systems; highlights that nccps should offer palliative care and a pain management plan for everyone who needs it , for the entire disease trajectory from the beginning and alongside the disease , for adults and also for children; urges the eu to work with member states to address barriers for palliative care , to provide palliative care through primary health care centres as well as at home , and promote palliative care education for all health professionals;


### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination; ### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , access to education , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination;


### 79. encourages member states to take into account the frequent exhaustion of the families and relatives of cancer patients and to provide them with psychological assistance and rest periods in the workplace; ### 79. encourages member states to take into account the frequent exhaustion of the families and relatives of cancer patients and to provide them with psychological and socio-economic assistance , especially for the most vulnerable ones , and rest periods in the workplace , along all the illness , as well as bereavement support;


### 79. encourages member states to take into account the frequent exhaustion of the families and relatives of cancer patients and to provide them with psychological assistance and rest periods in the workplace; ### 79. encourages member states to take into account the frequent exhaustion of the families and relatives of cancer patients and to provide them with psychological assistance rest periods in the workplace and to put in place adequate and accessible support systems;


### 80. recalls that patient empowerment is crucial for the european cancer strategy and that patient-centeredness and participatory decision-making must be at the heart of treatment and care development processes; encourages the therapeutic education of caregivers and patients and their empowerment in the care programmes; ### 80. recalls that patient empowerment is crucial for the european cancer strategy and that patient-centeredness and participatory decision-making must be at the heart of treatment and care development processes; encourages the therapeutic education of caregivers and patients and their empowerment in the care programmes; considers that , given the paediatric specific developmental characteristics , a specifically tailored methodology should be applied to the training and empowerment process of paediatric patients;


### 81. acknowledges the positive role of patients’ associations in relation to patient advocacy and accompaniment; calls on the commission and the member states to take into account their requests and recommendations when formulating cancer-related policies and legislation and to provide them with public support in order to guarantee their independence from private funding; ### 81. acknowledges the positive role of patients’ associations and young patients advisory groups (ypags) in relation to patient advocacy and accompaniment; calls on the commission and the member states to take into account their requests and recommendations when formulating cancer-related policies and legislation and to provide them with public support in order to guarantee their independence from private funding; considers that paediatric patients should play a role , both individually and collectively , in improving healthcare and research procedures for all patients by contributing with their specific experiences; takes the view , therefore , that adequate learning and educational tools should be developed to plan and ensure the involvement of children , which is properly financed;


### 81. acknowledges the positive role of patients’ associations in relation to patient advocacy and accompaniment; calls on the commission and the member states to take into account their requests and recommendations when formulating cancer-related policies and legislation and to provide them with public support in order to guarantee their independence from private funding; ### 81. acknowledges the positive role of patients’ associations in relation to patient advocacy , accompaniment and services provided to cancer patients and caregivers; calls on the commission and the member states to take into account their requests and recommendations when formulating cancer-related policies and legislation and to provide them with public support in order to guarantee their independence from private funding;


### 82. calls on the member states to improve the reintegration of cancer survivors into the labour market and to facilitate the return to school of paediatric cancer survivors; advocates specific eu recommendations for measures for cancer survivors to prevent the recurrence of primary cancer and the development of new cancers and for their rehabilitation; ### 82. calls on the member states to improve the reintegration of cancer survivors into the labour market and to facilitate the return to school of paediatric cancer survivors; advocates specific eu recommendations for measures for cancer survivors to prevent the recurrence of primary cancer and the development of new cancers and for their rehabilitation , including specific provisions for long-term follow-up care for childhood cancer survivors as they transition into adulthood;


### 83. considers that the european agency for health and safety at work should be mandated to play a stronger role in promoting good practices in member states with respect to the integration of cancer patients and survivors into the workplace and their protection from discrimination; looks forward to the new study , announced in europe’s beating cancer plan , on the return to work of cancer survivors , which will map national employment and social protection policies and identify obstacles and the remaining challenges; ### 83. considers that the european agency for health and safety at work should be mandated to play a stronger role in promoting good practices in member states with respect to the integration of cancer patients and survivors into the workplace and their protection from discrimination; looks forward to the new study , announced in europe’s beating cancer plan , on the return to work of cancer survivors , which will map national employment and social protection policies and identify obstacles and the remaining challenges , as well as the direct economic impact that cancer has on patients and their families , especially on those groups that are most vulnerable due to their socio-economic situation;


### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and doctors of the 1.3 million people who die from cancer each year in europe , including 6 000 children , the crucial needs of patients who are currently in need of efficient and innovative treatments , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments; ### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and doctors of the 1.3 million people who die from cancer each year in europe , including 6 000 children , the crucial needs of patients who are currently in need of efficient and innovative treatments for cancer and cancer-related complications and comorbidities , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments;


### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and doctors of the 1.3 million people who die from cancer each year in europe , including 6 000 children , the crucial needs of patients who are currently in need of efficient and innovative treatments , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments; ### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and healthcare professionals of the 1.3 million people who die from cancer each year in europe , including 6 000 children , the crucial needs of patients who are currently in need of efficient and innovative treatments , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments;


### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and doctors of the 1.3 million people who die from cancer each year in europe , including 6 000 children , the crucial needs of patients who are currently in need of efficient and innovative treatments , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments; ### a. whereas europe’s beating cancer plan should effectively respond to the call for progress by the families and doctors of the 1.3 million people who die from cancer each year in europe , including 6 000 children and young adults , the crucial needs of patients who are currently in need of efficient and innovative treatments , the rightful expectations of more than 12 million cancer survivors facing the difficult return back to a ‘normal life’ , the clear will of future generations to be protected against health threats , and the concern of governments facing a growing economic burden from cancer and its related treatments;


### c. whereas cancer illustrates social injustice in healthcare , as differences in cancer survival rates across the eu member states exceed 25 %; whereas eu citizens are unequal in terms of prevention , unequally protected against risk factors , unequally educated in terms of healthy behaviours and unequally equipped against misinformation; whereas eu citizens are unequal in terms of timely access to quality care from member state to member state and from region to region in any given country; whereas after recovery or when in remission , eu citizens are unequal in their ability to return to work , to be financially independent and to return to a harmonious familial , social and emotional life; ### c. whereas cancer illustrates social injustice in healthcare , as differences in cancer survival rates across the eu member states exceed 25 %;whereas eu citizens are unequal in terms of prevention , unequally protected against risk factors , unequally educated in terms of healthy behaviours and unequally equipped against misinformation; whereas eu citizens are unequal in terms of timely access to quality care and medical products from member state to member state and from region to region in any given country; whereas access to fully multidisciplinary and multi-professional medical teams varies widely across europe; whereas after recovery or when in remission , eu citizens are unequal in their ability to return to work , to be financially independent and to return to a harmonious familial , social and emotional life;


### c. whereas cancer illustrates social injustice in healthcare , as differences in cancer survival rates across the eu member states exceed 25 %; whereas eu citizens are unequal in terms of prevention , unequally protected against risk factors , unequally educated in terms of healthy behaviours and unequally equipped against misinformation; whereas eu citizens are unequal in terms of timely access to quality care from member state to member state and from region to region in any given country; whereas after recovery or when in remission , eu citizens are unequal in their ability to return to work , to be financially independent and to return to a harmonious familial , social and emotional life; ### c. whereas cancer illustrates social injustice in healthcare , as differences in cancer survival rates across the eu member states exceed 25 %; whereas eu citizens are unequal in terms of prevention , unequally protected against risk factors , unequally educated in terms of healthy behaviours and unequally equipped against misinformation; whereas eu citizens are unequal in terms of timely access to quality care from member state to member state and from region to region in any given country; whereas access to fully multidisciplinary and multi-professional teams varies widely across europe; whereas after recovery or when in remission , eu citizens are unequal in their ability to return to work , to be financially independent and to return to a harmonious familial , social and emotional life;


### f. whereas health literacy includes the acquisition of knowledge and skills , awareness of rights and the confidence to take action to improve personal and community health; whereas actions to promote health literacy under the plan should focus on empowering patients and citizens; whereas all efforts to increase health literacy should take into account people with learning disabilities , as well as ensure that the necessary information is available in common non-eu languages in order to reach migrants and new arrivals; ### f. whereas health literacy includes the acquisition of knowledge and skills , awareness of rights and the confidence to take action to improve personal and community health; whereas actions to promote health literacy under the plan should focus on empowering patients and citizens , including paediatric patients; whereas patient empowerment requires assisting patients understand their rights , including specifically as cancer patients; whereas all efforts to increase health literacy should take into account people with learning disabilities and children and adolescents who need to be informed according to their age and degree of maturity , as well as ensure that the necessary information is available in common non-eu languages in order to reach migrants and new arrivals; whereas efforts to improve health literacy should also include an onus on assisting citizens to identify misinformation , noting the harmful impacts this can have across all areas of cancer care including prevention , vaccination and treatment.


### f. whereas health literacy includes the acquisition of knowledge and skills , awareness of rights and the confidence to take action to improve personal and community health; whereas actions to promote health literacy under the plan should focus on empowering patients and citizens; whereas all efforts to increase health literacy should take into account people with learning disabilities , as well as ensure that the necessary information is available in common non-eu languages in order to reach migrants and new arrivals; ### f. whereas health literacy includes the acquisition of knowledge and skills , awareness of rights and the confidence to take action to improve personal and community health; whereas actions to promote health literacy under the plan should focus on empowering patients and citizens; whereas all efforts to increase health literacy should take into account people with learning disabilities , inequalities in knowledge , access and use of it technologies as well as ensure that the necessary information is available in common non-eu languages in order to reach migrants and new arrivals;


### g. whereas the plan should be implemented in close association with the recommendations and actions of the international agency for research on cancer (iarc) , the un sdgs for global health , and the recommendations and guidelines of the world health organization (who) , and should acknowledge as a priority the eu’s solidarity and partnership with low- and middle-income countries; ### g. whereas the plan should be implemented in close association with the recommendations and actions of the international agency for research on cancer (iarc) , the un sdgs for global health , and the recommendations and guidelines of the world health organization (who) , and should acknowledge as a priority the eu’s solidarity and partnership with low- and middle-income countries , including those in the wider who europe region;


### h. whereas addressing cancer could be used as a model for other non-communicable diseases , and whereas patients with other chronic diseases should therefore also benefit from the achievements of europe’s beating cancer plan; ### h. whereas addressing cancer could be used as a model for other non-communicable diseases , and whereas patients with other chronic diseases should therefore also benefit from the achievements and principles of europe's beating cancer plan and going forward to build similar plans for other pathologies with high mortality rates;


### j. whereas a comprehensive , multidisciplinary and coordinated approach to addressing social , individual , environmental and commercial health determinants is needed at regional , national and european level in order to support actions targeting all aspects of cancer (prevention , detection , treatment , palliative care and reintegration) through the effective mobilisation of key tools such as research and knowledge sharing; whereas new technologies and artificial intelligence have high potential for improvements in the field of cancer research; ### j. whereas a comprehensive , multidisciplinary and coordinated approach to addressing social , individual , environmental and commercial health determinants is needed at regional , national and european level in order to support actions targeting all aspects of cancer (prevention , detection , treatment , palliative care and reintegration) through the effective mobilisation of key tools such as research and knowledge sharing; whereas patient-centric approaches to treatment such as integrative oncology , based on scientific evidences , have shown to improve the quality of life and overall survivorship of patients; whereas new technologies and artificial intelligence have high potential for improvements in the field of cancer research;


### j. whereas a comprehensive , multidisciplinary and coordinated approach to addressing social , individual , environmental and commercial health determinants is needed at regional , national and european level in order to support actions targeting all aspects of cancer (prevention , detection , treatment , palliative care and reintegration) through the effective mobilisation of key tools such as research and knowledge sharing; whereas new technologies and artificial intelligence have high potential for improvements in the field of cancer research; ### j. whereas a comprehensive , multidisciplinary and coordinated approach to addressing social , individual , environmental and commercial health determinants is needed at regional , national and european level in order to support actions targeting all aspects of cancer (prevention , detection , treatment , palliative care and reintegration) through the effective mobilisation of key tools such as research and knowledge sharing; whereas new technologies and artificial intelligence have high potential for improvements in the field of cancer research , deployment of treatment and care;


### m. whereas europe’s beating cancer plan could therefore represent the first step towards a real european health union; ### m. whereas europe’s beating cancer plan could therefore represent the first step towards a real european health union and a public demonstration to citizens of the success that eu health cooperation can achieve;


### 2. calls on the commission and member states to design and implement effective prevention measures at national and eu level , based on best practices , independent expertise and guidance; ### 2. calls on the commission and member states to design and implement effective risk and harm-reducing prevention measures at national and eu level , based on best practices , risk proportionality , independent scientific expertise and guidance;


### 3. acknowledges that more than 40 % of all cancers are preventable through coordinated actions on social , individual , environmental and commercial health determinants; ### 3. acknowledges that more than 40 % of all cancers are preventable through coordinated actions on social , individual , environmental and commercial health determinants; reiterates at the same time that there should be increased focus on screening , diagnosis and treatment initiatives for those cancers that cannot be prevented , such as blood cancers , under europe's beating cancer plan;


### 5. deplores the significant health inequalities in the eu as regards cancer prevention; insists on the need to pay special attention to vulnerable and marginalised populations in order to ensure their access to cancer prevention services; ### 5. deplores the significant health inequalities in the eu as regards cancer prevention; insists on the need to pay special attention to vulnerable and marginalised populations in order to ensure their access to cancer prevention services include access to the appropriate tools and services to prevent transmission of carcinogenic viruses like human papilloma virus (hpv) and hepatitis b (hbv) and c (hcv);


### 5. deplores the significant health inequalities in the eu as regards cancer prevention; insists on the need to pay special attention to vulnerable and marginalised populations in order to ensure their access to cancer prevention services; ### 5. deplores the significant health inequalities in the eu as regards cancer prevention; insists on the need to pay special attention to vulnerable and marginalised populations in order to ensure their access to cancer prevention services , such as smoking cessation services , obesity treatment and hpv vaccination;


### 7. strongly supports the goal of a ‘tobacco-free generation’ , as set out in europe’s beating cancer plan , where less than 5 % of the population uses tobacco by 2040 , compared to around 25 % today; ### 7. strongly supports the goal of a ‘tobacco-free generation’ , as set out in europe’s beating cancer plan , where less than 5 % of the population uses tobacco by 2040 , compared to around 25 % today; urges that progress towards interim goals towards this target be reported within the cancer inequalities registry in order to best direct efforts to achieve the overall target;


### an increase in minimum excise duties for all tobacco products , which could result in a reduction in tobacco use , notably among young people; ### an introduction of , and increase in , minimum excise duties for all tobacco and nicotine products proportionate to the health risks they represent to their users , which shall result in a reduction in tobacco and nicotine users , notably among current smokers and prevent young people from starting smoking;


### a ban on flavourings in all tobacco products to reduce the appeal of these products to non-smokers and young people; ### a ban on smoking tobacco flavourings and a ban on flavours in all nicotine products to reduce the appeal of these products to smokers and to prevent non-smokers in particular young people from starting smoking;


### an authorisation for member states to introduce a ban on plastic cigarette filters on health and environmental grounds; ### a re-iteration of the call to member states to implement the obligations under the single use plastics directive (directive (eu) 2019/904) as regards filters in tobacco products containing plastics;


### an authorisation for member states to introduce a ban on plastic cigarette filters on health and environmental grounds; ### a call for member states to introduce recyclable and biodegradable alternatives to plastic cigarette filters on health and environmental grounds;


### the continuation of evaluations of the health risks related to electronic cigarettes and the establishment of a list of substances contained and emitted by these products at european level , based on the model published by the french agency for health security; ### the continuation of evaluations of the health risks related to electronic cigarettes including the assessment of relative and absolute harm of electronic cigarettes , novel tobacco products and smoke-less tobacco products compared to cigarettes and tobacco smoking , and the establishment of a list of substances contained and emitted by these products at european level , based on the model published by the french agency for health security;


### the continuation of evaluations of the health risks related to electronic cigarettes and the establishment of a list of substances contained and emitted by these products at european level , based on the model published by the french agency for health security; ### the continuation of evaluations of the health risks related to electronic cigarettes , heated tobacco products and the establishment of a list of substances contained and emitted by these products at european level , based on the model published by the french agency for health security;


### 11. recalls that ethanol and acetaldehyde in alcoholic beverages are classified as carcinogenic to humans by the iarc , and that in europe an estimated 10 % of all cancer cases in men and 3 % of all cancer cases in women are attributable to alcohol consumption; ### 11. recalls that acetaldehyde from ethanol metabolism is classified as carcinogenic to humans by the iarc , and that in europe an estimated 4.3 % of all cancer cases are attributable to harmful alcohol consumption;


### 11. recalls that ethanol and acetaldehyde in alcoholic beverages are classified as carcinogenic to humans by the iarc , and that in europe an estimated 10 % of all cancer cases in men and 3 % of all cancer cases in women are attributable to alcohol consumption; ### 11. recalls that ethanol and acetaldehyde in alcoholic beverages are classified as carcinogenic to humans by the iarc , and that in europe an estimated 10 % of all cancer cases in men and 3 % of all cancer cases in women are attributable to harmful alcohol consumption;


### 86. calls on the commission to support the european code of cancer care launched by the european cancer organisation (eco) , which is an empowering and informative tool to ensure that the best available care is provided to european citizens and patients; ### 86. calls on the commission to support the european code of cancer practice launched by the european cancer organisation (eco) , which is an empowering and informative tool to ensure that the best available care is provided to european citizens and patients; underscores that this support should include assistance in awareness raising and promotion;


### 88. calls for clear policy requirements on paediatric cancer research needs; calls on member states and the commission to redress the unequal allocation of investment to paediatric cancers; considers that a clear and specific eu funding stream should be dedicated to paediatric cancer research and budget allocations earmarked across all relevant eu programmes; ### 88. calls for clear policy requirements on paediatric cancer research needs; calls on member states and the commission to redress the unequal allocation of investment to paediatric cancers; considers that a clear and specific eu funding stream should be dedicated to paediatric cancer research and budget allocations earmarked across all relevant eu programmes including in the horizon europe cancer mission;


### 88. calls for clear policy requirements on paediatric cancer research needs; calls on member states and the commission to redress the unequal allocation of investment to paediatric cancers; considers that a clear and specific eu funding stream should be dedicated to paediatric cancer research and budget allocations earmarked across all relevant eu programmes; ### 88. calls for clear policy requirements on paediatric cancer research needs; calls on member states and the commission to redress the unequal allocation of investment to paediatric cancers; considers that a clear and specific eu funding stream should be dedicated to paediatric cancer treatment and research and budget allocations earmarked across all relevant eu programmes;


### 89. calls on the commission and the member states to focus on ensuring equal access to the best specialist diagnostics and multi-disciplinary treatment for children with cancer , and to improve cancer treatment outcomes in all member states; considers that the professional figure of the paediatric oncologist should be recognised in all member states; ### 89. calls on the commission and the member states to focus on ensuring equal and geographically balanced access to the best specialist diagnostics and multi-disciplinary treatment for children with cancer , and to improve cancer treatment outcomes in all member states; considers that the professional figure of the paediatric oncologist should be recognised in all member states;


### 91. stresses the need to strengthen the right to cross-border care for children and aya cancer patients when the best treatment is not available in their country of residence; ### 91. stresses the need to strengthen the right to cross-border care for children and aya cancer patients when the best treatment is not available in their country of residence; stresses the need to ensure that access to innovation in early clinical trials for difficult-to-treat malignancies in children adolescents and young adults (ayas) is covered by the relevant provisions;


### 91. stresses the need to strengthen the right to cross-border care for children and aya cancer patients when the best treatment is not available in their country of residence; ### 91. stresses the need to strengthen the right to cross-border care , including access to innovation in early clinical trials , for children and aya cancer patients when the best treatment is not available in their country of residence;


### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs , identify the most important drugs to meet the needs of children with poor prognostic cancers , reduce delays so that children can have faster access to paediatric drugs , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027; ### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs , identify the most important drugs to meet the needs of children with poor prognostic cancers as well as incentivise the first-in-child development of new paediatric anticancer medicines , reduce delays so that children can have faster access to paediatric drugs , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027;


### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs , identify the most important drugs to meet the needs of children with poor prognostic cancers , reduce delays so that children can have faster access to paediatric drugs , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027; ### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs , identify the most important drugs to meet the needs of children with poor prognostic cancers , reduce delays so that children can have faster access to paediatric drugs , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027; considers , consequently , that ad hoc funding for paediatric research should be included in the horizon europe call for grants , and that a clear obligation to include paediatric research should be considered as a condition for application;


### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs , identify the most important drugs to meet the needs of children with poor prognostic cancers , reduce delays so that children can have faster access to paediatric drugs , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027; ### 92. calls for an ambitious revision of the regulations on paediatric33 and orphan34 medicinal products in order to ensure access to innovative cancer drugs and transformative therapies , identify the most important drugs to meet the needs of children with poor prognostic cancers , reduce delays so that children can have faster access to paediatric drugs including transformative therapies such as cell and gene therapies , and address limited access to certain essential medicines due to drug shortages and the high price of innovative medicines; recommends an increase of 20 % in the available new paediatric cancer drugs by 2027;


### 96. supports the recommendation of the joint action on rare cancers for the roll-out of a european unique patient identifier , in order to ensure the monitoring of long-term outcomes in childhood cancer survivors in a cross-border setting; ### 96. supports the recommendation of the joint action on rare cancers for the roll-out of a european unique patient identifier , and guidelines on long-term surveillance and transition from paediatric to adult care in order to ensure the monitoring of long-term outcomes in childhood cancer survivors in a cross-border setting;


### 97. stresses that europe’s beating cancer plan should be implemented in close cooperation with the cancer mission under horizon europe and its objectives of promoting eu investment in cancer research and innovation; ### 97. stresses that europe’s beating cancer plan should be implemented in close cooperation with the cancer mission under horizon europe and its objectives of promoting eu investment in cancer research and innovation; recommends that no less than 20 % of cancer research funds in horizon europe be dedicated to new paediatric cancer medicines in order to fill the existing gap in paediatric medicines;


### 97. stresses that europe’s beating cancer plan should be implemented in close cooperation with the cancer mission under horizon europe and its objectives of promoting eu investment in cancer research and innovation; ### 97. stresses that europe’s beating cancer plan should be implemented in close cooperation with the cancer mission under horizon europe and its objectives of promoting eu investment in cancer research and innovation; calls for paediatric cancer research to have a dedicated partnership in "cluster 1: health" of the horizon europe pillar ii funding programme;


### 98. recalls that cancer research , and its translation into everyday clinical practice , is fundamental to ensuring continuous improvements in cancer prevention , diagnosis , treatment and follow-up care for survivors; welcomes , therefore , the launch of horizon europe partnerships to translate scientific knowledge into innovations; ### 98. recalls that cancer research , and its translation into everyday clinical practice , is fundamental to ensuring continuous improvements in cancer prevention , diagnosis , treatment and follow-up care for survivors; welcomes , therefore , the launch of horizon europe partnerships to translate scientific knowledge into innovations; underlines that these partnerships should include paediatric competences and issues;


### 98. recalls that cancer research , and its translation into everyday clinical practice , is fundamental to ensuring continuous improvements in cancer prevention , diagnosis , treatment and follow-up care for survivors; welcomes , therefore , the launch of horizon europe partnerships to translate scientific knowledge into innovations; ### 98. recalls that cancer research , and its translation into everyday clinical practice , is fundamental to ensuring continuous improvements in cancer prevention , diagnosis , treatment and follow-up care for survivors; welcomes , therefore , the launch of horizon europe partnerships to translate scientific knowledge into innovations; recommends that the cited partnerships include paediatric competences and issues;


### 99. reiterates its call for sustainable and adequate funding for competitive european research on cancer; calls for at least a 20 % increase in the mobilisation of public and private research on therapeutic and diagnostic cancer innovations; ### 99. reiterates its call for sustainable and adequate funding for competitive european research on cancer; calls for at least a 20 % increase in the mobilisation of public and private research on therapeutic and diagnostic cancer innovations , covering all concerned patient populations;


### 100. stresses the need for independent and multidisciplinary research on cancer ‘from bench to bedside’ , that is from the laboratory to applied studies in patients; urges the establishment of measures to limit misinformation , especially on social media; ### 100. stresses the need for independent and multidisciplinary research on cancer ‘from bench to bedside’ , that is from the laboratory to applied studies in patients; urges the establishment of measures to limit misinformation , especially on social media; requests specific measures to protect children and young people from disinformation;


### 102. considers the significant potential impact of the use of artificial intelligence and modern technologies in diagnosis and decision-making for cancers in the coming years; encourages the commission and the member states to promote the knowledge of cancer biology through the implementation of genomics and informatics infrastructures; ### 102. considers the significant potential impact of the use of artificial intelligence and modern technologies in diagnosis and decision-making for cancers in the coming years; encourages the commission and the member states to promote the knowledge of cancer biology through the implementation of genomics and informatics infrastructures; urges all implementation partners to be ever mindful of the principles of trust , transparency , patient centricity and patient involvement at all times;


### 106. welcomes the planned partnership for personalised medicine , announced in europe’s beating cancer plan and to be funded under horizon europe , which will identify priorities for research and education in personalised medicine , support research projects on cancer prevention , diagnosis and treatment , and make recommendations for the roll-out of personalised medicine approaches in daily medical practice; supports the establishment of a roadmap for personalised prevention allowing for the identification of gaps in research and innovation and for the mapping of all known biological anomalies leading to cancer susceptibility , including hereditary factors; ### 106. welcomes the planned partnership for personalised medicine , announced in europe’s beating cancer plan and to be funded under horizon europe , which will identify priorities for research and education in personalised medicine , support research projects on cancer prevention , diagnosis and treatment , including in paediatrics , and make recommendations for the roll-out of personalised medicine approaches in daily medical practice; supports the establishment of a roadmap for personalised prevention allowing for the identification of gaps in research and innovation and for the mapping of all known biological anomalies leading to cancer susceptibility , including hereditary factors and paediatric issues;


### 107. encourages research on non-profit clinical trials to improve treatment strategies , with a focus on the elderly; ### 107. encourages research on non-profit clinical trials to improve treatment strategies , with a focus on the elderly and children;


### 108. calls on the commission and the member states to promote studies dedicated to human and social sciences , in particular those addressing health inequalities at the different stages of cancer diseases; ### 108. calls on the commission and the member states to promote studies dedicated to human and social sciences , in particular those addressing health inequalities at the different stages of cancer diseases; stresses that this should include attention to inequalities in cancer care related to such factors as gender , age , and socio-economic status , including marginalised groups in society;


### 111. strongly believes that patient associations should be involved in defining research endpoints for clinical trials , in order to ensure that the trials address the unmet needs of european patients; considers that the final results of the trials should be communicated to the participating patients and to the public; ### 111. strongly believes that patient associations should be involved in defining research endpoints for clinical trials , in order to ensure that the trials address the unmet needs of european patients; considers that the final results of the trials should be communicated to the participating patients and to the public; stresses that paediatric patients should be involved in the definition of unmet needs , and can provide input in the design of the protocol , improve communication with the target population and enhance methods for dissemination of findings;


### 112. advocates more transparency in the process of research into and the development of cancer treatments , including the establishment of a portal to allow patients access to information on the available clinical trials in europe; ### 112. advocates more transparency in the process of research into and the development of cancer treatments , including the establishment of a portal to allow patients access to information on the available clinical trials in europe; underlines that this should also include information tailored to children and young patients;


### 114. asks the commission to assess the functioning of the european reference networks (erns) , especially their role in gathering and sharing expertise and best practices , thus rationalising patient referral in the management of rare cancers , which affect an estimated 5.1 million patients across europe and require cooperation on a large scale; ### 114. asks the commission to assess the functioning of the european reference networks (erns) , especially their role in gathering and sharing expertise and best practices , thus rationalising patient referral in the management of rare cancers , which affect an estimated 5.1 million patients across europe and require cooperation on a large scale; emphasises the importance of the erns with regard to overcoming health inequalities and ensuring safer and high-quality treatment across eu borders;


### 115. emphasises the need to secure sustained long-term funding for the erns; supports the expansion of the erns to specific types of cancer (rare , complex , poorly curable) and paediatric cancers; ### 115. calls on the commission and the member states to secure appropriate and long-term funding for the erns and to ensure effective reimbursement of patient travel costs when this is required , in order to foster improved standards of care and equal access to the best possible interventions to all patients who require them across europe; supports the expansion of the erns to specific types of cancer (rare , complex , poorly curable);


### 115. emphasises the need to secure sustained long-term funding for the erns; supports the expansion of the erns to specific types of cancer (rare , complex , poorly curable) and paediatric cancers; ### 115. emphasises the need to secure sustained long-term funding for the erns; supports the expansion of the erns to specific types of cancer (rare , complex , poorly curable) and paediatric cancers as it could facilitate equal access of patients , including children and aya , to the best available care across europe;


### 116. believes that the revamping of erns will necessarily involve the participation of all member states in existing erns , with each member state having at least one ‘full’ or ‘affiliate’ member in each ern , the facilitation of the individual patient journey through the effective collaboration of national contact points with erns , the evaluation of the functioning of the erns by sharing data on their performance and networking in the field of rare cancers , the deployment of telemedicine tools allowing for the sharing of case records and imaging results , and the allocation of adequate and long-term funding , both at union (eu4health) and national level; ### 116. believes that the consolidation and further development of the erns will necessarily involve the participation of all member states in existing erns , with each member state having at least one ‘full’ or ‘affiliate’ member in each ern , the facilitation of the individual patient journey through the effective collaboration of national contact points with erns , the evaluation of the functioning of the erns by sharing data on their performance and networking in the field of rare cancers , the deployment of telemedicine tools allowing for the sharing of case records and imaging results , and the allocation of adequate and long-term funding , both at union (eu4health) and national level;


### 117. encourages member states to support a dedicated and tailored approach to rare cancers in adults and paediatric cancers , taking stock of eu initiatives , and to fully integrate erns into their national healthcare systems; ### 117. encourages member states to support a dedicated and tailored approach to rare cancers in adults and paediatric cancers , taking stock of eu initiatives , and to fully integrate erns into their national healthcare systems; recommends that member states establish national networks for rare adult cancers in order to optimise the referral of patients to specialised centres in a timely fashion and facilitate interaction with erns;


### 120. recommends the creation of at least one cancer registry in each eu region , including remote and outermost regions; supports the strengthening of the capacity of national cancer registries to collect data (including lifestyle and socio-economic information) to better identify the causes of inequalities in cancer incidence , prevalence and survival; asks member states to ensure the comparability of data sources and the interoperability of regional and national cancer registries; ### 120. recommends the creation of at least one cancer registry in each eu region , including remote and outermost regions; supports the strengthening of the capacity of national cancer registries to collect data (including lifestyle and socio-economic information) to better identify the causes of inequalities in cancer incidence , prevalence and survival; asks member states to ensure the comparability of data sources and the interoperability of regional and national cancer registries; calls for the implementation of specific cancer registries for paediatric malignancies in line with the international classification of childhood cancer (iccc);


### 121. strongly supports the creation of a cancer inequalities registry at european level , announced in europe’s beating cancer plan , in order to identify trends , disparities , inequalities and inequities between and within member states; believes that this registry will help to identify challenges and specific areas of action so as to guide investment and intervention at eu , national and regional level; ### 121. strongly supports the creation of a cancer inequalities registry at european level , announced in europe’s beating cancer plan , in order to identify trends , disparities , inequalities and inequities between and within member states; believes that this registry will help to identify challenges and specific areas of action so as to guide investment and intervention at eu , national and regional level; calls for making the registry accessible to the public;


### f) generating a comprehensive model based on europe’s beating cancer plan and horizon europe in order to identify research priorities and possibly enable the development of a coordinated and efficient cancer research force in europe; ### f) generating a comprehensive model based on europe’s beating cancer plan and horizon europe in order to identify research priorities and possibly enable the development of a coordinated and efficient cancer research force in europe with the input from patients and carers;


### 125. emphasises that europe’s beating cancer plan should not only be seen as a political commitment to driving change but as a set of concrete and ambitious initiatives that will support , coordinate and complement member states’ efforts to reduce the suffering caused by cancer; stresses that , in order for the initiatives outlined in the plan to be translated into concrete actions , these initiatives have to be adequately funded; underlines , however , the differing capacity of member states to absorb the funds dedicated to healthcare programmes thus far; ### 125. emphasises that europe’s beating cancer plan should not only be seen as a political commitment to driving change but as a set of concrete and ambitious initiatives that will support , coordinate and complement member states’ efforts to reduce the physical and mental suffering caused by cancer; encourages the commission to optimise the coherent implementation of the initiatives outlined in the plan , with clear guidance to member states regarding concrete actions against unequal access to cancer diagnosis and treatment , as well as adequate funding; underlines , however , the differing capacity of member states to absorb the funds dedicated to healthcare programmes thus far; calls on the commission to provide member states with guidance and a clear overview of the dedicated eu resources , the specifically defined pathways that link the actions outlined in the plan with the eu funding mechanisms identified in it , as well as the possible synergies and complementarities with other eu financing instruments;


### — having regard to the outcomes of the first intergovernmental conference with albania of 19 july 2022 , ### — having regard to the outcomes of the first intergovernmental conference with albania of 19 july 2022 and to the opening of accession negotiations with albania ,


### — having regard to the declarations of the eu-western balkans summits , held in zagreb on 6 may 2020 , brdo pri kranju on 6 october 2021 and tirana on 6 december 2022 , ### — having regard to the declarations of the eu-western balkans summits , held in sofia on 17 may 2018 , zagreb on 6 may 2020 , brdo pri kranju on 6 october 2021 and tirana on 6 december 2022 ,


### a. whereas enlargement is the most effective eu foreign policy instrument and represents a geostrategic investment in long-term peace , democracy , stability and security throughout the continent; ### a. whereas the rules and values based enlargement is the most effective eu foreign policy instrument and represents a geostrategic investment in long-term peace , democracy , stability and security throughout the continent;


### c. whereas democratic transformation , the rule of law and reconciliation play a central role in the eu accession process; ### c. whereas democratic transformation , the rule of law and reconciliation play a central role in the eu accession process and each accession country should demonstrate robust irreversible results in democratic resilience and socio-economic transformation;


### e. whereas accession negotiations mark a new phase in eu-albania relations and demand a united commitment in order to prepare for eu membership; ### e. whereas accession negotiations are a clear recognition of the progress achieved and mark a new phase in eu-albania relations and demand a united commitment in order to prepare for eu membership;


### f. whereas the eu remains the main political and economic partner of the western balkan countries; ### f. whereas the eu remains the main political and economic partner of the western balkan countries , mobilising an unprecedented cross-cutting additional support in the wake of the pandemics and russia’s brutal aggression against ukraine; ;


### 1. welcomes albania’s steadfast commitment to eu integration , reflecting the consensus among political parties and overwhelming support among citizens; commends its solidarity and consistent , full alignment with the eu’s foreign and security policy , including its clear-cut response to the russian war of aggression against ukraine; ### 1. welcomes albania’s steadfast commitment to eu integration , reflecting the consensus among political parties and overwhelming support among citizens; commends its solidarity , good neighbourly relations , regional cooperation and consistent , full alignment with the eu’s foreign and security policy , including its clear-cut response to the russian war of aggression against ukraine;


### 1. welcomes albania’s steadfast commitment to eu integration , reflecting the consensus among political parties and overwhelming support among citizens; commends its solidarity and consistent , full alignment with the eu’s foreign and security policy , including its clear-cut response to the russian war of aggression against ukraine; ### 1. welcomes albania’s steadfast strategic commitment to eu integration , reflecting the consensus among political parties and overwhelming support among citizens; commends its solidarity and consistent , full alignment with the eu’s foreign and security policy , including its clear-cut response to the russian war of aggression against ukraine;


### 2. encourages its policymakers to accelerate the reforms that enabled the first long overdue intergovernmental conference and a successful start to the screening process , and to demonstrate steady progress in guaranteeing democracy , the rule of law and fundamental rights; urges decision-makers to work jointly towards meeting the membership criteria by 2030; stresses the need to strengthen the transparency , accountability and inclusiveness of the accession process , including its parliamentary dimension; ### 2. encourages its policymakers to accelerate the reforms that enabled the first long overdue intergovernmental conference and a successful start to the screening process , and to demonstrate steady progress in guaranteeing democracy , the rule of law and fundamental rights; urges decision-makers to work jointly towards meeting the membership criteria by 2030; stresses the need to strengthen the transparency , accountability and inclusiveness of the accession process by the government , including its parliamentary dimension;


### 4. commends albania’s commitment to completing its comprehensive justice reform; encourages the country to intensify steps aimed at finalising the vetting process and ensuring universal justice through cross-cutting measures; ### 4. commends albania’s commitment to completing its comprehensive justice reform and looks forward to its implementation; encourages the country to intensify steps aimed at finalising the vetting process and ensuring universal justice through cross-cutting measures;


### 6. calls on the albanian authorities to address the outstanding electoral and party financing recommendations well ahead of the 2025 parliamentary elections; ### 6. calls on the albanian authorities to urgently address the outstanding electoral and party financing recommendations well ahead of the 2025 parliamentary elections;


### 7. insists on adequate funding for and the effective and impartial functioning of independent bodies and agencies; recognises the contribution of independent civil society and the media in the fight against corruption; ### 7. insists on adequate funding for and the effective and impartial functioning of independent bodies and agencies; recognises the contribution of independent civil society and the media in the fight against corruption and stresses the importance of their effective involvement on eu integration and other consultative mechanisms , as legitimate partners in the process;


### 7. insists on adequate funding for and the effective and impartial functioning of independent bodies and agencies; recognises the contribution of independent civil society and the media in the fight against corruption; ### 7. insists on adequate funding for and the effective and impartial functioning of independent bodies and agencies; recognises the contribution of civil society and the media in the fight against corruption;


### 8. notes the ongoing progress and looks forward to systematic improvements in the prevention , proactive investigation and prosecution of and non-selective final convictions for cases involving corruption and organised crime; calls for further progress in establishing a comprehensive , efficient , soundly coordinated and accountable public administration; ### 8. notes the ongoing progress and looks forward to systematic improvements and concrete results in the prevention , proactive investigation and prosecution of and non-selective final convictions for cases involving corruption and organised crime; calls for further progress in establishing a comprehensive , efficient , soundly coordinated and accountable public administration;


### 9. expresses its concern with the aspects of the draft law on fiscal amnesty and the proposed citizenship by investment scheme that are incompatible with eu norms and its visa policy; ### 9. expresses its concern with the aspects of the draft law on fiscal amnesty and the proposed citizenship by investment scheme that are incompatible with eu norms and its visa policy and would pose risks as regards security , money laundering , tax evasion , terrorist financing , corruption and infiltration by organised crime ; welcomes prime minister rama’s announcement to suspend the golden passport project;


### 10. calls for continued action to reduce unfounded asylum claims by albanian nationals , while tackling criminal trafficking networks and increasing cooperation with the eu’s justice and home affairs agencies; welcomes successful international investigations and police operations to combat the trafficking of people , narcotics and firearms , and online fraud; ### 10. calls for continued action to reduce unfounded asylum claims by albanian nationals , while tackling criminal trafficking networks and increasing cooperation with the eu’s justice and home affairs agencies; welcomes successful international investigations and police operations to combat the trafficking of people , narcotics and firearms , and online fraud; stresses that countering cybercrime , trafficking in human beings and money laundering remain areas in which additional results are needed; calls on the authorities to step up its fight against child sexual abuse online which remains a concern;


### 12. condemns malign foreign interference and hybrid attacks , including disinformation , espionage , incitement to all forms of radicalisation and cyberattacks against albanian citizens and critical infrastructure; invites the authorities to prevent data leaks by considerably strengthening cybersecurity; ### 12. condemns malign foreign interference and hybrid attacks , including disinformation , espionage , incitement to all forms of radicalisation and cyberattacks against albanian citizens and critical infrastructure; condemns the irresponsible use of the private data of citizens by one political party; calls on the authorities to take measures to prevent data leaks by considerably strengthening cybersecurity and accelerate efforts to align its legislation with the eu acquis on personal data protection;


### 13. notes the legal steps taken to eliminate discrimination against minorities , and calls for practical steps in order to ensure their inclusion , namely the inclusion of lgbti+ , roma and egyptian minorities; recalls the need to combat gender-based violence , step up child protection , adopt and implement legislation on minority rights , strengthen property rights and conduct a population census; underlines the importance of removing barriers to the socioeconomic inclusion of persons with disabilities; ### 13. notes the legal steps taken to eliminate discrimination against minorities , and calls for practical steps in order to ensure their inclusion , namely the inclusion of lgbti+ , roma and egyptian minorities; recalls the need to combat gender-based violence , step up child protection , adopt and implement legislation on minority rights , strengthen property rights and conduct a population census according to european standards; underlines the importance of removing barriers to the socioeconomic inclusion of persons with disabilities;


### 13. notes the legal steps taken to eliminate discrimination against minorities , and calls for practical steps in order to ensure their inclusion , namely the inclusion of lgbti+ , roma and egyptian minorities; recalls the need to combat gender-based violence , step up child protection , adopt and implement legislation on minority rights , strengthen property rights and conduct a population census; underlines the importance of removing barriers to the socioeconomic inclusion of persons with disabilities; ### 13. notes the legal steps taken to eliminate discrimination against minorities , and calls for practical steps in order to ensure their inclusion , namely the inclusion of lgbti+ , roma and egyptian minorities; urges the authorities to step up their work to combat gender-based violence , step up child protection , adopt and implement legislation on minority rights , strengthen property rights and conduct a population census; underlines the importance of removing barriers to the socioeconomic inclusion of persons with disabilities;


### 14. expresses its concern with the lack of progress on achieving institutional transparency , freedom of expression and media freedom and stresses the role of political leaders in creating an enabling environment for the pursuit of these freedoms; condemns attempts to discredit reporters and arbitrarily withhold public information , as well as the failure to ensure the safety of journalists; urges the authorities to take immediate action against political and economic interference in the media and intimidation against reporters; welcomes the withdrawal of the draft anti-defamation legislation; urges the government to ensure the independence of the public broadcaster and media regulator and the transparency of media ownership , financing and public advertising; ### 14. expresses its concern with the lack of progress on achieving institutional transparency , freedom of expression and media freedom and stresses the role of political leaders in creating an enabling environment for the pursuit of these freedoms; condemns attempts to discredit reporters and arbitrarily withhold public information , as well as the failure to ensure the safety of journalists; urges the authorities to take immediate action against political and economic interference in the media and intimidation against reporters; condemns any regulatory attempts aiming at increasing the political control over media institutions; welcomes in this context the withdrawal of the draft anti-defamation legislation; deplores the fact that only a minority of albanian media have a sustainable business model and transparent funding; urges the government to ensure the independence of the public broadcaster and media regulator and the transparency of media ownership , financing and public advertising;


### 15. urges the authorities to counter disinformation and manipulative narratives by promoting media literacy and improving the working conditions of journalists; ### 15. urges the authorities to counter disinformation and manipulative narratives by promoting media literacy and improving the working conditions of journalists; welcomes the work of the alliance for ethical media of albania aiming at rigorously implementing the code of ethics of journalists; calls on the association of professional journalists of albania and its members to adhere to the highest industry standards , in particular by adopting the journalism trust initiative set up by reporters without borders , to maintain trust and fight against disinformation;


### 16. underlines the importance of an inclusive framework for meaningful civil society engagement in decision-making processes; ### 16. underlines the importance of an inclusive framework for meaningful civil society engagement in decision-making processes; calls on the authorities to build trust and ensure they are given opportunities of involvement , at both national and local governmental level , to actively participate in the eu integration processes through effectively functioning of the mechanisms in place;


### a. whereas enlargement is the most effective eu foreign policy instrument and is a geostrategic investment in long-term peace; ### a. whereas the rules and values based enlargement is the most effective eu foreign policy instrument and is a geostrategic investment in long-term peace , democracy , stability and security throughout the continent;


### c. whereas democratic transformation , the rule of law and reconciliation play a central role in eu accession; ### c. whereas democratic transformation , the rule of law and reconciliation play a central role in eu accession process and each accession country should demonstrate robust irreversible results in democratic resilience and socio-economic transformation;


### d. whereas russia’s war of aggression against ukraine highlights the critical importance of eu enlargement; ### d. whereas russia’s war of aggression against ukraine highlights the critical importance of eu enlargement and exposes the need to increase resilience to malign foreign interference into democratic processes , aiming to destabilise the region by sowing discord and provoking tensions and violence;


### d. whereas russia’s war of aggression against ukraine highlights the critical importance of eu enlargement; ### d. whereas russia’s war of aggression against ukraine has considerable potential to further destabilise many eu and non-eu countries , especially those in the western balkans and the eastern partnership and highlights the critical importance of eu enlargement;


### e. whereas the fight against corruption , malicious foreign interference , money laundering and organised crime is a european security issue; ### e. whereas the fight against corruption , malicious foreign interference , money laundering and organised crime is a european security issue , crucial for north macedonia’s and other enlargement countries’ progress in the eu accession;


### f. whereas each country should be judged on its own merits and whereas the accession process should not be misused to settle bilateral disputes; ### f. whereas each country should be judged on its own merits and the conditionality-based accession process should not be misused to settle bilateral disputes;


### g. whereas the eu remains the main political and economic partner of the western balkan countries; ### g. whereas the eu remains the main political and economic partner of the western balkan countries , mobilising an unprecedented cross-cutting additional support in the wake of the pandemics and russia’s brutal aggression against ukraine;


### h. whereas accession negotiations mark a new phase in eu–north macedonia relations; ### h. whereas accession negotiations are a clear recognition of the progress achieved and mark a new phase in eu–north macedonia relations;


### 1. welcomes north macedonia’s consistent commitment to eu integration , which has been underpinned by steady progress on guaranteeing democracy , the rule of law and fundamental rights , while moving towards cross-cutting policy alignment; ### 1. welcomes north macedonia’s consistent strategic commitment to eu integration , which has been underpinned by solidarity and steady progress on guaranteeing democracy , the rule of law and fundamental rights , while moving towards cross-cutting policy alignment with the eu;


### 2. commends north macedonia’s full alignment with the eu’s foreign and security policy , including its clear-cut response to the aggression against ukraine by aligning with the eu’s restrictive measures against russia and belarus; ### 2. commends north macedonia’s full alignment with the eu’s foreign and security policy , including its clear-cut response to the aggression against ukraine by aligning with the eu’s restrictive measures against russia and belarus; expresses its full support to north macedonia's osce chairmanship and its role in contributing to peace and stability and safeguarding the respect for international law; welcomes reforms undertaken so far in the fields of crisis management , the critical infrastructure , cyber defence , participation in the eu and nato-led missions and the ongoing modernization of armed forces;


### 2. commends north macedonia’s full alignment with the eu’s foreign and security policy , including its clear-cut response to the aggression against ukraine by aligning with the eu’s restrictive measures against russia and belarus; ### 2. commends north macedonia’s full alignment with the eu’s foreign and security policy , including its clear-cut response to the russian aggression against ukraine by aligning with the eu’s restrictive measures against russia and belarus;


### 3. urges decision-makers to foster a national consensus on eu integration , building upon a successful start to the screening process , to work towards the ambitious goal of meeting the criteria for eu membership by 2030; ### 3. urges decision-makers to foster a national consensus on eu integration , to work towards strengthening administrative capacities , building upon a successful start to the screening process , to work towards fulfilment and the ambitious goal of meeting the criteria for eu membership by 2030;


### 5. compliments north macedonia for the tangible results in consolidating democracy; urges the country to intensify efforts to improve governance and access to justice; ### 5. compliments north macedonia for the tangible results in consolidating democracy; urges the country to intensify efforts to improve governance and access to justice through the implementation of roadmaps on the rule of law and public administration;


### 6. invites policymakers to constructively engage in the continued adoption and implementation of structural reforms , while strengthening decision-making transparency , inclusive consultations and the oversight abilities of the assembly of north macedonia , including under the auspices of the jean monnet dialogue; ### 6. invites policymakers to constructively engage in the continued adoption and implementation of structural eu-related reforms under a cross-party commitment to the eu integration , while strengthening specialised independent institutions , decision-making transparency , inclusive consultations and the oversight abilities of the assembly of north macedonia , including under the auspices of the jean monnet dialogue , facilitated by the european parliament; urges lawmakers to implement a pending commitment to revise sobranie’s rules of procedure , to avoid both unjustified delays and the overuse of urgency procedures and to strengthen parliamentary oversight over the intelligence services;


### 8. encourages the country to increase institutional integrity and intensify its judicial reform; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations; applauds anti-corruption contribution of independent civil society and the media; ### 8. encourages the country to increase institutional integrity and intensify its judicial reform; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations such as the commission for prevention of corruption (scpc) , the public prosecution office; applauds anti-corruption contribution of independent civil society and the media; supports enhanced judicial cooperation in criminal matters under the working arrangement with the eppo in order to ensure effective investigation and prosecution of crimes against the european union’s budget;


### 8. encourages the country to increase institutional integrity and intensify its judicial reform; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations; applauds anti-corruption contribution of independent civil society and the media; ### 8. encourages the country to increase institutional integrity and intensify its judicial reform to guarantee the independence , professionalism , transparency and impartiality of the judicial system; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations; applauds anti-corruption contribution of independent civil society and the media;


### 8. encourages the country to increase institutional integrity and intensify its judicial reform; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations; applauds anti-corruption contribution of independent civil society and the media; ### 8. encourages the country to increase institutional integrity and intensify its judicial reform; welcomes prosecutions related to the abuse of office and looks forward to systematic action to prevent , prosecute and follow-up on corruption cases; insists on adequate funding for and the effective functioning of independent bodies and agencies and on the consistent implementation of their decisions and recommendations; applauds anti-corruption contribution of civil society and the media;


### 9. urges the authorities to effectively fight corruption and organised crime through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases involving high-level corruption , organised crime and money laundering; ### 9. urges the authorities to effectively fight corruption and organised crime through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases involving high-level corruption , organised crime and money laundering , making a full use of the national coordination centre for the fight against organised and serious crime;


### 9. urges the authorities to effectively fight corruption and organised crime through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases involving high-level corruption , organised crime and money laundering; ### 9. urges the authorities to effectively fight corruption and organised crime in a more consistent and productive way , through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases involving high-level corruption , organised crime and money laundering;


### 9. urges the authorities to effectively fight corruption and organised crime through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases involving high-level corruption , organised crime and money laundering; ### 9. urges the authorities to effectively fight corruption and organised crime through coordinated investigations and prosecutions leading to final convictions and asset confiscations in cases of corruption including high-level corruption , organised crime and money laundering;